Nozawa, Kazutaka
Higa, Shingo
Ii, Yoichi
Yamamoto, Yuji
Asami, Yuko
Funding for this research was provided by:
Pfizer
Article History
Accepted: 19 January 2021
First Online: 9 March 2021
Compliance with ethical standards
:
: This research was sponsored and funded by Pfizer Japan Inc.
: KN, SH, and YA are full-time employees of Pfizer Japan Inc., and hold Pfizer stock. YI is a full-time employee of Pfizer R&D Japan and holds Pfizer stock. YY has no conflicts of interest to declare.
: This study involved data that exist in an anonymized structured format and contained no personal information. Studies exclusively using unlinkable anonymized data are outside the scope of the “Ethical Guidelines for Medical and Health Research Involving Human Subjects” by the Japanese government. Therefore, obtaining informed consent and approval from the ethical review committee was not required for this study.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available from the database maintained by MinaCare Co., Ltd. (Tokyo, Japan), independent of Pfizer Japan Inc. Pfizer Japan Inc. is not involved in validating or storing the data included in the database. Restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission from MinaCare Co., Ltd.